These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1784070

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
    Urabe A, Takaku F, Mizoguchi H, Nomura T, Aoki N, Yamaguchi H, Mutoh Y, Miura Y, Toyama K, Hirashima K.
    Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813
    [Abstract] [Full Text] [Related]

  • 23. [Clinical experience with fosfomycin sodium for infectious diseases in obstetrics and gynecology].
    Yamazaki T, Ogura T, Kawamura M.
    Jpn J Antibiot; 1983 Aug; 36(8):2115-9. PubMed ID: 6655829
    [Abstract] [Full Text] [Related]

  • 24. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
    Sawae Y, Niho Y, Harada M, Shibuya T, Okamura T, Asano Y, Taniguchi S, Murakawa M, Toyoshima T, Kozuru M.
    Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effects of ceftriaxone on severe infectious complications in hematological disorders. Tohkai Research Group on Infections in Hematological Disorders].
    Mitomo Y, Nitta M, Kodama H, Kobayashi M, Ikeda Y, Kodera Y, Matsushita T, Ohara K, Kamiya O, Shirakawa S.
    Jpn J Antibiot; 1989 Apr; 42(4):938-47. PubMed ID: 2671428
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical evaluation of panipenem/betamipron as a second line chemotherapy in severe infections associated with hematological disorders].
    Nakazawa N, Okamoto T, Kobayashi M, Iwai T, Sasai Y, Tamura A, Horiike S, Yokota S, Taniwaki M, Kashima K, Misawa S, Tuda S, Ohkawara Y.
    Jpn J Antibiot; 1998 Aug; 51(8):509-20. PubMed ID: 9836123
    [Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The use of SM-4300 against severe infections complicated with hematological diseases].
    Ikeda S, Ichimaru M.
    Jpn J Antibiot; 1985 Sep; 38(9):2559-63. PubMed ID: 4079021
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.